This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Neoadjuvant Chemotherapy or Combined Chemo-Radiation Therapy of Pancreatic Ductal Adenocarcinoma Differentially Shift Immune Activation, ECM Composition, Energy Metabolism, and Ribosomal Proteins of the Residual Tumor Mass, March 2023, Research Square,
DOI: 10.21203/rs.3.rs-2607052/v1.
You can read the full text:
The following have contributed to this page
